AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sutykine 12.5mg Capsule

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Sunitinib (12.5mg)

Overview Sutykine 12.5mg Capsule

Oncaspase 12.5mg capsules are indicated for kidney cancer and gastrointestinal stromal tumor treatment. Their mechanism involves inhibiting specific enzymes crucial for cancer cell proliferation, thereby reducing tumor size and growth rate. These capsules may be administered with or without food, but consistent daily timing optimizes therapeutic efficacy. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdosage can lead to severe adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include fatigue, loose stools, nausea, vomiting, altered taste perception, and reduced appetite. Regular blood pressure and thyroid function monitoring may be recommended. Hypoglycemia, potentially severe enough to cause fainting, is possible; diabetics should monitor blood glucose levels frequently and discuss potential anti-diabetic medication adjustments with their doctor. Prior to commencing treatment, inform your physician of any pre-existing heart, liver, kidney conditions, or bleeding disorders. Drug interactions are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout the treatment period.

Uses of Sutykine 12.5mg Capsule

Managing Renal Cell Carcinoma and Gastrointestinal Stromal Tumors

Major Benefits of Sutykine 12.5mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sutykine 12.5mg Capsules. These capsules can be taken with or without food, however, consistent timing is recommended.

Common Side effects of Sutykine 12.5mg Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Sutykine 12.5mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sutykine 12.5mg Capsules. These capsules can be ingested with or without food, though consistent timing is recommended.

How Sutykine 12.5mg Capsule works:

Sutykine 12.5mg capsules are an anticancer drug that targets tyrosine kinase, a protein on the surface of cancer cells. By binding to and inhibiting this protein, Sutykine impedes cancer cell growth and the formation of new blood vessels that feed tumors, thus suppressing malignant proliferation.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction between Sutykine 12.5mg Capsule and alcohol is undetermined. Medical advice is recommended before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sutykine 12.5mg Capsules during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sutykine 12.5mg capsules while breastfeeding is likely inadvisable. Available data from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Using Sutykine 12.5mg Capsules might lead to adverse effects that impair driving ability. Dizziness is a possible side effect of this medication. Refrain from driving or operating machinery if dizziness occurs during treatment.

KidneyKidneySAFE IF PRESCRIBED

Sutykine 12.5mg capsules pose no safety concerns for individuals with kidney impairment; dosage modification is unnecessary.

LiverLiverSAFE IF PRESCRIBED

Sutykine 12.5mg capsules may be administered to patients with hepatic impairment without modification of the prescribed dosage.

What if you forget to take Sutykine 12.5mg Capsule :

Omit any missed Sutykine 12.5mg Capsule dose and resume your regular dosing regimen. Avoid taking a double dose.

Facts to Know About Sutykine 12.5mg Capsule

LabelValue
Chemical Category Indole and Pyrrole Derivatives
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Sutykine 12.5mg Capsule

Follow your doctor's instructions precisely when taking Sutykine 12.5mg Capsules. This medication should only be initiated by physicians experienced in cancer treatment. Take one capsule daily, with or without food. Avoid grapefruit juice and grapefruit during treatment to minimize potential side effects.
Sutykine 12.5mg Capsules may cause skin lightening and hair loss. You might also experience dryness, thickening, cracking, blisters, or rashes on your palms and soles. While these side effects usually disappear after stopping treatment, serious, potentially fatal skin reactions like severe rash or rapidly spreading skin ulceration are possible. Report any signs of infection near a skin injury (fever, pain, redness, swelling, pus, or bleeding) to your doctor immediately.
Sutykine 12.5mg Capsules may cause life-threatening liver damage. Report itching, yellowing of eyes or skin, dark urine, or right upper stomach pain or discomfort to your doctor immediately. Your doctor will monitor your liver function with blood tests before and during treatment. Treatment may be temporarily or permanently stopped if liver problems develop.
Sutykine 12.5mg Capsules have no generic equivalents. They function by inhibiting protein kinase, an enzyme on the surface of cancer cells that drives their growth and spread. This inhibition prevents cancer progression. Other protein kinase inhibitors include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
Sutykine 12.5mg Capsules lack supporting research for concurrent use with other chemotherapy drugs. Its application in Gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, is specifically for cases where imatinib, another anticancer drug, is ineffective or unsuitable.
Yes, Sutykine 12.5mg Capsules can lower blood sugar. Diabetics should monitor their blood sugar closely, as dangerously low levels can cause unconsciousness. Your diabetic medication dosage may need adjustment based on these readings.
Sutykine 12.5mg Capsules may raise blood pressure. Regular blood pressure monitoring is essential. Report severe headache, dizziness, lightheadedness, or vision changes to your doctor immediately. They may adjust your medication or temporarily suspend treatment to manage your blood pressure.
Sutykine 12.5mg Capsule
399
MRP 462
13% off